Mutational analysis of an autoantibody: differential binding and pathogenicity

Area of Science:

• Immunology
• Molecular Biology
• Nephrology

Background:

• Pathogenic anti-double-stranded DNA (dsDNA) antibodies are implicated in autoimmune diseases like lupus.
• The R4A antibody is a well-characterized pathogenic anti-dsDNA antibody model.
• Understanding the molecular basis of anti-dsDNA antibody pathogenicity is crucial for therapeutic development.

Purpose of the Study:

• To investigate how specific amino acid substitutions in the R4A antibody heavy chain affect its DNA binding properties.
• To determine the impact of these mutations on the antibody's pathogenicity in vivo.
• To explore the relationship between DNA binding affinity and pathogenic mechanisms of anti-dsDNA antibodies.

Main Methods:

• Site-directed mutagenesis was employed to introduce single amino acid substitutions in the R4A antibody heavy chain.
• DNA binding assays were performed to assess changes in antigen recognition and affinity.
• In vivo studies using mouse models were conducted to evaluate the pathogenicity and tissue localization of mutated antibodies.

Main Results:

• Single amino acid substitutions, even in framework regions, significantly altered dsDNA binding, with some ablating specificity and others increasing affinity 10-fold.
• Mutations leading to loss of dsDNA binding also resulted in decreased glomerular sequestration.
• Increased dsDNA affinity caused a shift in immunoglobulin deposition from glomeruli to renal tubules.

Conclusions:

• Small changes in amino acid sequence can profoundly impact both the antigen-binding properties and pathogenicity of anti-dsDNA antibodies.
• The pathogenicity of anti-dsDNA antibodies does not strictly correlate with their affinity for dsDNA.
• These findings highlight the complex interplay between antibody structure, function, and disease manifestation in autoimmune conditions.